Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
The emergence of Plasmodium falciparum parasites resistant to artemisinins compromises the efficacy of Artemisinin Combination Therapies (ACTs), the global first-line malaria treatment. Artemisinin resistance is a complex genetic trait in which nonsynonymous SNPs in PfK13 cooperate with other geneti...
Prif Awduron: | Nayak, S, Peto, TJ, Kucharski, M, Tripura, R, Callery, JJ, Quang Huy, DT, Gendrot, M, Lek, D, Nghia, HDT, van der Pluijm, RW, Dong, N, Long, LT, Vongpromek, R, Rekol, H, Hoang Chau, N, Miotto, O, Mukaka, M, Dhorda, M, von Seidlein, L, Imwong, M, Roca, X, Day, NPJ, White, NJ, Dondorp, AM |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Nature Research
2024
|
Eitemau Tebyg
-
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
gan: Nayak, Sourav, et al.
Cyhoeddwyd: (2025) -
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
gan: Sourav Nayak, et al.
Cyhoeddwyd: (2024-12-01) -
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
gan: Peto, TJ, et al.
Cyhoeddwyd: (2022) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
gan: van der Pluijm, RW, et al.
Cyhoeddwyd: (2022) -
Triple artemisinin-based combination therapies for malaria – a new paradigm?
gan: van der Pluijm, RW, et al.
Cyhoeddwyd: (2020)